1. Cabozantinib in patients with platinum-refractory metastatic urothelial carcinoma: an open-label, single-centre, phase 2 trial. Issue 8 (August 2020) Authors: Apolo, Andrea B; Nadal, Rosa; Tomita, Yusuke; Davarpanah, Nicole N; Cordes, Lisa M; Steinberg, Seth M; Cao, Liang; Parnes, Howard L; Costello, Rene; Merino, Maria J; Folio, Les R; Lindenberg, Liza; Raffeld, Mark; Lin, Jeffrey; Lee, Min-Jung; Lee, Sunmin; Alarcon, Sylvia V; Yuno, Akira; Dawson, Na... Journal: Lancet oncology Issue: Volume 21:Issue 8(2020) Page Start: 1099 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Mechanisms of acquired resistance to androgen receptor targeting drugs in castration-resistant prostate cancer. Issue 11 (November 2014) Authors: Chism, David D; De Silva, Dinuka; Whang, Young E Journal: Expert review of anticancer therapy Issue: Volume 14:Issue 11(2014) Page Start: 1369 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗